News & Events
ACTRIMS Forum 2020
Attending the ACTRIMS Forum 2020? Visit our virtual “booth” to talk to one of our team members.
AAIC 2020
Attending AAIC 2020? “Stop by” our virtual booth to speak to one of our team members.
cDSI helps doctors decide which Alzheimer’s patients are appropriate for lumbar puncture
Alzheimer’s proteins in the cerebrospinal fluid play an increasingly important role in an accurate diagnosis. In this article, Dr. Hanneke Rhodius-Meester of the Alzheimer Center Amsterdam explains how cDSI can help doctors decide which patients are appropriate for a lumbar puncture.
RSNA 2019
Attending RSNA 2019? Speak with one of our team members at booth 10532B during the show.
Combinostics raises €3.9M to support early Alzheimer’s diagnosis
Combinostics is pleased to announce the closure of a €3.9M series A funding round to extend the company’s cNeuro platform in the US and Asia.
Combinostics partners with Nihon Medi-Physics to develop and market cNeuro platform in Japan
Combinostics is pleased to announce an exclusive partnership with Nihon Medi-Physics to develop and market the cNeuro platform in Japan.
Three peer-reviewed, scientific publications that describe the use of cNeuro
Three peer-reviewed, scientific journals have published articles that describe the use of the cNeuro platform for dementias and other cognitive disorders.
Combinostics selected to join the 2019 MassChallenge HealthTech cohort
Combinostics has been selected to join the 2019 MassChallenge HealthTech cohort which represents the most innovative technologies advancing health and improving the overall patient experience.
